Evaluation and management of urinary tract infections in the neonate

Area of Science:

• Pediatric Nephrology
• Neonatal Infectious Diseases
• Urology

Background:

• Urinary tract infections (UTIs) affect up to 1.1% of full-term neonates, rising to 7% in febrile infants.
• Neonatal UTIs can be the initial sign of congenital kidney and urinary tract abnormalities.
• Early detection and management are vital to prevent renal sequelae.

Purpose of the Study:

• To review current strategies for diagnosing and managing UTIs in neonates.
• To highlight the importance of identifying underlying renal and urinary tract abnormalities.
• To discuss evolving approaches to UTI management and prophylaxis in infants.

Main Methods:

• Review of recent findings on UTI diagnosis and risk factor detection in neonates.
• Analysis of current diagnostic imaging techniques, including DMSA scans and ultrasound.
• Evaluation of emerging serum and urine markers for UTI diagnosis.
• Assessment of prophylactic strategies for recurrent UTIs.

Main Results:

• Established diagnostic and prophylactic strategies for neonatal UTIs are under debate.
• Renal changes are key indicators for risk factors like vesicoureteral reflux, with DMSA scans often emphasized.
• Serum and urine markers may enable more selective diagnostic imaging.
• Prenatal and postnatal ultrasounds offer opportunities for early intervention.

Conclusions:

• Preventing infection-related complications and renal damage are primary goals in managing neonatal UTIs.
• Parenteral antibiotics are mandatory for neonates with suspected pyelonephritis.
• Diagnostic imaging should be risk-oriented, prioritizing noninvasive methods.
• The efficacy of antibacterial prophylaxis for preventing recurrent UTIs in at-risk infants requires further evidence.